NCT00241826View on ClinicalTrials.gov

Prospective Investigation of Pulmonary Embolism Diagnosis III

CompletedOBSERVATIONAL
Enrollment

1,256

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

April 30, 2009

Conditions
Lung DiseasesPulmonary Embolism
Interventions
PROCEDURE

Magnetic Resonance Angiography

Participants will undergo magnetic resonance angiography.

PROCEDURE

Magnetic Resonance Venography

Participants will undergo magnetic resonance venography.

Trial Locations (9)

10016

NYU Medical Center, New York

20852

Data Coordinating Center, Rockville

20892

Divison of Lung Diseases, NHLBI, Bethesda

30308

Emory University, Atlanta

48109

University of Michigan Medical Center, Ann Arbor

48341

St. Joseph Mercy-Oakland, Pontiac

63110

Washington University Medical Center, St Louis

02114

Massachusetts General Hospital, Boston

T2N 2T9

Foothills Hospital, Calgary

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

George Washington University

OTHER

NCT00241826 - Prospective Investigation of Pulmonary Embolism Diagnosis III | Biotech Hunter | Biotech Hunter